Search


	Podcast:		BioCentury This Week
	Episode:		Ep. 260 - VC Funds, New Chapter for MS, Wave's Data
	Category:		Science & Medicine
	Duration:		00:31:18
	Publish Date:		2024-10-22 01:00:00
	Description:		At least 25 venture firms have raised a total of more than $17 billion in funds this year, with Forbion unveiling the largest-ever European biopharma fund at €1.2 billion last week. On the latest BioCentury This Week podcast, BioCentury’s editors discuss how Forbion deployed its prior fund and quickly raised fresh funds and what that — and other funds — say about the state of financing private biotechs in Europe and elsewhere. The editors then assess takeaways from BioCentury’s conversation with NIH’s Daniel Reich on data that could shape drug development’s future for progressive multiple sclerosis, and neurodegeneration broadly, as well as how the first clinical data from an RNA-editing oligonucleotide therapy from Wave Life Sciences demonstrate that it’s possible to change a single base in an RNA to correct a disease-causing mutation in patients. View full story: https://www.biocentury.com/article/653924 00:00 - Introduction 02:48 - VC Funds 11:50 - New Chapter for MS 23:48 - Wave's Data To submit a question to BioCentury’s editors, email the BioCentury This Week team at podcasts@biocentury.com. Reach us by sending a text
	Total Play:		0